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INTRODUCTION
The Japanese Society of Hospital Pharmacists (JSHP) is promoting the prior avoidance of adverse drug reactions under its program,``PRE-AVOID'' (``be prepared to avoid the adverse reaction of drugs). 1) Avoiding negative drug interactions and side eŠects is a core responsibility of pharmacists in the management of patient safety. From February 1999, our society has been collecting PRE-AVOID incidents from hospitals in every Japanese prefecture and metropolitan area. Inˆscal year (FY) 2015, 39770 cases were reported. 2) It has become clear that when each medical facility analyzes collected PRE-AVOID incidents, pharmacist intervention in drug treatment can contribute to improved pharmacotherapy safety. 3) Certain hospital pharmacists are improving their daily work quality by creating``Items Requiring Conˆrmation'' for their pharmaceutical care, basing these instructions on their collected PRE-AVOID case reports. 4) Meanwhile, JSHP is analyzing its collected PRE-AVOID cases to determine the background of these adverse reactions and related factors, and develop future improvement policies. The aim is to enable community pharmacists to have a visual representation of the results of their work. 5) A variety of information can serve as sources for PRE-AVOID activities, including prescription documents, drug history, medical test results, and questions and concerns expressed by patients and their families. One important source is the drug proˆle book (DPB), a personal health record submitted by persons receiving prescription drugs. In the PRE-AVOID report by the Kurume Pharmaceutical Association, over 30％ of PRE-AVOID work was performed using the DPB as a basis; this suggests that pharmacists are keenly aware of the importance of the DPB in their daily PRE-AVOID work duties. 5) It is well known among pharmacists that the DPB is an eŠective means of ascertaining medical information of a patient, including pharmaceutical status; 6) eŠorts are also underway to promote among the public the recording into the DPB of other pertinent information, including the history of adverse reactions, lab test results, supplements taken, and general information on pharmaceuticals, by either the pharmacist or patients themselves. 7) The Japan Ministry of Health, Labour and Welfare (MHLW) has published the Pharmacy Vision for Patients, which aims at``greater uniformity in the management of patient pharmaceutical information''; the Vision indicates the DPB as an eŠective tool in achieving this goal. In these ways, the DPB thought to function as an information medium indispensable to patients in their reception of pharmacotherapy. Pharmacists must strive to su‹ciently enlighten patients of the role of the DPB. When patients also recognize its importance, it is likely to become the most important information source when performing PRE-AVOID-related activities.
Based on the above considerations, we thought that an awareness of PRE-AVOID focused on the use of the DPB by pharmacists could be linked to their previously existing eŠorts to enlighten patients of the roles and the DPB, and performed our survey accordingly. The present survey aims at (1) determining the status of awareness and self-conˆdence of pharmacists regarding PRE-AVOID, and (2) determining the extent to which pharmacists are striving to enlighten patients of the roles of the DPB.
METHODS

Survey Subjects
Subjects were pharmacists who work at 65 branch stores of two pharmacy chains, and who participated in the Visualization of Treatment Assist by Pharmacists (VISTA) Project. 8) The VISTA Project is a survey of pharmacists aimed at verifying the eŠects on medical-care safety of the eŠective use of the DPB.
Survey Method
In August 2015, study consent forms and survey questionnaires concerning the status of DPB usage were distributed to each of the participating pharmacies. Request was made for individuals toˆll out the questionnaires after agreeing to and signing the said consent forms.
Survey Items
The questionnaire used in this study requested pharmacists to record their personal attributes, namely, sex and number of years of drugpreparation experience. Question items were, 1-1. Awareness concerning PRE-AVOID work using the DPB (i.e., awareness of PRE-AVOID work); 1-2. Self-conˆdence concerning PRE-AVOID work using the DPB (i.e., self-conˆdence in PRE-AVOID work); 2. Status of educating patients of the merits of the DPB (i.e., educating the merits); 3. Status of educating patients of the utilities of the DPB (i.e., educating the utilities); 4. Status of educating the roles of the DPB (i.e., educating the roles); 5. Status of guidance provided on methods of using the DPB; and 6. Pharmacist's interactions with the patients (i.e., interactions with patients). Table 1 shows the detailed contents of each survey item. As for survey items 2 to 5, there were modiˆcations of items used in previous researches. 9 11) Analysis Method Multiple regression analysis (stepwise method) was performed with the dependent variables of``Awareness of PRE-AVOID work: 1-1'', and``Self-conˆdence in PRE-AVOID work: 1-2'', with independence variables of``educating the merits: 2'',``educating the utilities: 3'',``educating the roles: 4'',``Status of guidance provided on methods of using the DPB: 5'', and``Interactions with patients: 6''. Statistical signiˆcance level was set at less than 5％, and IBM SPSS Statistics 21 was used for analyses.
Ethical Considerations
This study was performed after having obtained approval from the Osaka University of Pharmaceutical Sciences Research Ethics Committee (Approval Number: 0023).
RESULTS
Survey Subjects
Filled-out questionnaires were received from 240 pharmacists at 65 pharmacies. Sex distribution was male: 44 persons, female: 196 persons; mean number of years of drug preparation was 9.5 years (S.D.: 7.8 years).
Awareness and Self-conˆdence concerning PRE-AVOID Work``Awareness of PRE-AVOID work'' was a 10-point scale evaluation, and the number that the most persons selected as applying to them was 10, followed by 8.``Self-conˆdence in PRE-AVOID work'' was a 10-point scale evaluation, and the number that the most persons selected as applying to them was 6, followed by 7. Mean values for`A wareness of PRE-AVOID work'' and``Self-conˆ-dence in PRE-AVOID work'' were 8.4 (S.D.: 1.6) and 6.1 (S.D.: 1.7), respectively. These results suggest that although there is an awareness of the importance of PRE-AVOID, many pharmacists have low self-conˆdence regarding their own abilities to perform PRE-AVOID (Fig. 1) .
Status of Education regarding DPB Merits, Utilities, and Roles
The item with the highest percentage for the responses``I think so''' and``I think so, a 2) Do you have self-conˆdence in your ability to perform PRE-AVOID work using the DPB?``S elf-conˆdence in PRE-AVOID work''
[10-point scale (1: I do not think so/not self-conˆdent 10: I think so/self-conˆdent)]
2. Status of educating patients of the merits of the DPB 1) I communicate the fact that the DPB can be used to conˆrm that one is taking multiple medications.``P reventing concomitant drug usage''
2) I communicate the fact that the DPB can be used to help prevent side eŠects.``Preventing side eŠects'' 3) I communicate the fact that the DPB can be helpful at and during hospitalization.``H elpfulness at and during hospitalization'' 4) I communicate the fact that an accurate record of medicines being taken can be kept.``K eeping an accurate record of medicines being taken'' 5) I communicate the fact that the DPB can be used to conˆrm the medications one is taking during a natural disaster or other emergency.``H elpfulness during an emergency'' little'' was``Preventing concomitant drug usage'', followed by``Keeping an accurate record of medicines being taken''. The items with the highest mean value was also``Preventing concomitant drug usage'' (mean: 4.5, S.D.: 0.64), followed by``Keeping an accurate record of medicines being taken'' (mean: 4.3, S.D.: 1.7). Meanwhile, the item with the lowest percentage for the responses``I think so'' and``I think so, a little'' was``Helpfulness at and during hospitalization'' (Fig. 2) .
Status of Guidance Provided regarding the Methods of Using the DPB As for guidance provided regarding DPB usage methods, the item for which``I do so'' had the highest response percentage was``Not using multiple DPBs at same time'' (93.6 ％) followed by``Pasting the sticker every time'' (82.2％). The response rates for``I do so'' for`R ecording of OTC drugs and health supplements'' and``Recording of lab test results (values)'' were 37.3％ and 25.5％, respectively. These results demonstrate that although guidance is being provided regarding the collection of all previous information, within a single DPB and the placement of drug-information stickers, there is limited guidance being oŠered regarding other health-management support and beneˆts that the use of the DPB makes available (Fig. 3) .
Interactions with Patients
The item with the highest totals for``Always'' and``Most of the time'' was``Questions'', followed by``Blood test''. The item with the highest mean values was also``Questions'' (mean: 4.3, S.D.: 0.68), followed by``Blood test'' (mean: 4.1, S.D.: 0.87). Mean values for``Exercise and diet habits'' and``Anxieties'' were 3.8 (S.D.: 0.71) and 4.0 (S.D.: 0.75), respectively. Thus, a trend was observed such that patients only ask pharmacists questions concerning the drugs they are prescribed, but they ask for the pharmacists' advice concerning, among others, their private lives (Fig.  4) .
Factors Having EŠects on Awareness and Self-condence concerning the Work of PRE-AVOID Work For``Self-conˆdence in PRE-AVOID work'', a regression equation was derived that included three items, namely``, Educating the roles'',``Blood test'', and``Not using multiple DPBs at same time'', The item having the highest eŠect on``Self-conˆdence in PRE-AVOID work'' was``Educating the roles'' (standardized coe‹cient: 0.28), followed in order bỳ`B lood test'' and``Not using multiple DPBs at same time'' (with coe‹cients of 0.22 and 0.17, respectively). Although the same multiple regression analysis was performed for``Awareness of PRE-AVOID work'', no signiˆcant regression equation was derived ( Table 2) .
DISCUSSION
Our survey found that although community pharmacists are aware of the importance of PRE-AVOID, they have little conˆdence in actually performing it (Fig. 1) . Further, the results of the multiple regression analysis suggest that an eŠective way of building the self-conˆdence of pharmacists in performing PRE-AVOID is to encourage these professionals to perform``Educating the roles'' and``Not using multiple DPBs at same time'', and to involve themselves in conversations with patients who ask``Blood test'' ( Table 2) .
It was``Educating the roles'' that had the greatest impact on self-conˆdence; we, thus, used this item as a dependent variable, and survey questionnaire items 2 and 3 as independent variables, to perform multiple regression analysis further. The aim was to investigate the relationship between``Educating the roles'' and concrete educational (i.e., patient enlightenment) activities ( Table 3) . For``Educating the roles'', a regression equation was derived that included four items, namely,``Educating the utilities'',``Helpfulness during an emergency'',``Preventing concomitant drug usage'', and``Helpfulness at and during hospitalization''. As pharmacists educate the public of the roles of the DPB, they should include explanations regarding these four items, as our results show the importance of providing such comprehensive education to patients in PRE-AVOID work; moreover, doing so is also important in improving the self-conˆdence of individual pharmacists. Regarding``Not using multiple DPBs at same time'', persons who responded``I do so'' exceeded 80％ (Fig. 3) , indicating that a majority of pharmacists are informing patients not to use multiple DPBs. Meanwhile, in the category included in the same item,`G uidance provided on methods of using the DPB'', there were low percentages of persons who responded`I do'' to``Recording of OTC drugs and health supplements'' and``Recording of lab test results (values)'' (Both of these were under 50％). This suggests that recordings within the DPB are limited in many cases to only prescribed drugs, indicating that the DPB is used in only few cases as a general health handbook for recording of, among others, lab test results. Although it was not derived in the result of multiple regression analysis, the pharmacists who answered``I do so'' to the question of``Recording of OTC drugs and health supplements'' and``Recording of lab test results (values)'' tended to have higher`A wareness'' scores in our survey ( Table 4) . From this, promoting the utilization of DPB as a general health handbook is considered to be useful for improving the awareness of PRE-AVOID work.
Prior studies have suggested that even when the DPB is carried by a patient, many facts are not being recorded into the DPB. 7) The results of the present study support these previousˆndings. It is, thus, thought that future eŠorts need to focus on educating the public on the need to record within the DPB a wide variety of medical information (e.g., OTC drugs and supplements, etc.).
Regarding``Blood test'' over 80％ of the pharmacists responded between 4: Somewhat often and 6: Always (Fig. 4) . The results suggest that pharmacists are involved in a question-answer type of conversations with patients regarding medical lab test results (i.e., the numerical values of said results). Nonhospital prescriptions in recent years have included clinical test values, and certain hospitals are providing patient information to dispensing pharmacies within their routine activities. Therefore, one hopes that pharmacists will perform PRE-AVOID work that is even more based on these clinical test values. 12) Our survey can be said to show that when physicians obtain clinical test value-related information, this contributes to bolstering their self-conˆdence.
Limitations of our survey are presented below. First is the point that each of our evaluation items used a subjective ordinal scale. Second was the point that the adjusted R 2 value was low at 0.20 ( Table 2) . The third point is the fact that ceiling eŠects occurred for a number of our items used to determine relationships between awareness of PRE-AVOID work and the status of patient-directed education regarding the DPB (Fig. 1) . Because the pharmacists who served as our survey subjects had a mean 9.5 years of experience in preparing drugs, certainly they already had a high level of PRE-AVOID experience within their previous daily work. Future surveys will have to make discriminations between pharmacists in terms of their number of years of experience preparing drugs and the actual status of PRE-AVOID awareness among physicians with few years of such experience; the latter will also need to be surveyed.
Although the above-described limitations did exist, our study does have signiˆcance in that it has clariˆed the fact that when pharmacists provide thorough and detailed guidance regarding the use of the DPB, such experiences serve to increase the self-conˆdence of pharmacists regarding their abilities to perform PRE-AVOID work. We plan to conduct more surveys in the future, to determine any changes that might occur in the PRE-AVOID awareness of pharmacists as they proceed in providing the kind of guidance and patient-directed DPB-related education studied in our present survey. We also intend to conduct surveys that track how changes in awareness contribute to health care safety.
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